Log In
Print
BCIQ
Print
Print this Print this
 

Apidra, insulin glulisine

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionHuman insulin analog produced by recombinant DNA technology
Molecular Target Insulin receptor (INSR)
Mechanism of ActionInsulin receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsTreat hyperglycemia in Type II diabetics undergoing general surgery; Treat pediatric diabetes; Treat Type I and Type II diabetes; Treat Type I diabetes; Treat Type II diabetes
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today